|
 |
| Advisory
Board |
 |
 |
Samir
Bhatia, M.S. |
|
 |
Samir has over 15
years of experience in technology and off-shore
based companies. Prior to Scanris, Samir founded
and headed Tribiosys, Inc., a Boston based scientific
consulting firm. Before joining Tribiosys, Samir
was founder and CTO of StructuredMarkets, Inc.,
an online equity marketplace. At Systems Engineering
Associates, Samir managed Internet/e-commerce project
marketing and sales. Prior to SEA, Samir managed
the turnaround of Xscribe Corporation, as general
manager overseeing product design and development,
sales and marketing, and support functions. Mr.
Bhatia has a MS degree in Computer Science and an
M.S. degree in Physics from Northeastern University. |
|
|
Shiv
Tasker |
|
 |
Shiv Tasker, is currently
the CEO and founder of Bluespec, Inc., a company
that manufactures an industry standards-based Electronic
Design Automation (EDA) toolset. Shiv is also a
partner with Emsan Consulting, and heads the start
up and emerging growth company practice with focus
on business and marketing strategy. Prior to Emsan
Consulting, Shiv was the president and CEO of Phase
Forward, a software and service solution vendor
for the data collection and management of clinical
trials of new drugs and devices.
Prior to Phase Forward, Shiv was Sr. Vice President
for Worldwide Sales, Consulting Services and Corporate
Marketing at Viewlogic Systems Inc, a supplier of
complex electronic design automation tools for Integrated
Circuit and Printed Circuit Board design. As SVP
of Sales, Viewlogic had successive quarters of record
growth ($200M run rate) till the company’s
sale to a larger competitor. He improved service
gross margins from 27% to 62% within 6 quarters
and successfully branded the company away from its
historical slower growing products to a new set
of hot growth products that led to the company being
viewed as a serious acquisition target.
Mr. Tasker spent 8 years at Cadence Design Systems
in a variety of roles in marketing and general management
with ever increasing responsibility for product
lines and larger P&Ls. Prior to Cadence, he
was with Intergraph Corp for 5.5 years, initially
as a programmer and later as a marketer.
Mr. Tasker holds an MBA from the University of Texas
at Arlington and a BS from the University of Bombay
in Statistics and Economics. He is a member of the
Drug Information Association and works with the
Youth Technology Entrepreneurs, a non-profit organization
aimed at enriching high school curriculums with
real life technology skills – primarily in
lower income school districts. He was recently honored
by Mass Hi-Tech as an All-Star. |
|
|
|
|
Jennifer
Cotteleer, M.Sc. |
|
 |
Jennifer has over
20 years experience working with Fortune 100 technology
companies, and more than 30 global life sciences
companies of all sizes to develop successful business
and IT strategies and implementations. Currently,
Jennifer is the Chief Operating Officer at PharmaPros
Corporation, an outsourcing clinical data management
company. Before joining PharmaPros, Jennifer was
the Vice President of Service Operations and Technical
Support for Phase Forward, the industry’s
largest provider of clinical data management, electronic
data capture and adverse event management systems.
Prior to that she held positions as Manager, Clinical
Strategies and Technologies group for Computer Sciences
Corporation, Founder and Principal of The Decision
Company, and Consultant with Strategic Decisions
Group. Jennifer has an M.Sc. from the London Business
School, an M.S. in engineering-economic systems
and a B.S. in symbolic systems from Stanford University. |
|
|
|
|
Dr.
Peter A. Schad |
|
 |
Peter A. Schad, Ph.D. is currently the Senior
Director of Scientific Affairs for the American
College of Radiology (ACR), where he is in charge of
developing imaging business and CRO activities in
imaging research and clinical trials. Dr. Schad has
over 20 years of experience in the fields of
microbiology, genetics, bioinformatics,
computational biology and business planning and
development. Dr. Schad is on the Scientific Advisory
Board for the PhRMA foundation and several other
biotech companies. Dr. Schad was the CSO for two
biotech companies in the Boston area where he
managed functional genomics, bioinformatics and
computational biology as a discovery tool for
biomarker validation, drug discovery and business
development. While in the U.S. Army, Dr Schad
gained experience in hazardous microbiology and
enteric disease vaccine development at the Walter
Reed Army Institute of Research. His subsequent work
on pediatric vaccine development, at Praxis
Biologics, led to publication in the professional
journal Science. As a senior research scientist at
the Pathogenesis Corporation, he was a co-discoverer
of a correlation between Herpes Virus (HHV6) and
Multiple Sclerosis. Dr. Schad subsequently worked
at the National Center for Genome Resources (NCGR),
serving as principal investigator for the GSDB
database, one of four human genome databases in
existence at the time.
Dr. Schad received his Ph.D. in Microbiology and
Immunology from the Oregon Health Sciences
University, his M.S. in Microbiology from The
Catholic University of America, and his B.A. in
Biology from Rutgers University. |
|
|
|
|
Madhav
Anand, M.S. |
|
 |
Madhav has over 15 years of experience in business
strategy, business process, information technology,
and data management systems consulting. Mr. Anand is
a founding partner at Usheron Ventures, LLC, a
provider of funding and strategic guidance to
technology start-ups. Prior to Usheron, Mr. Anand
was the president and founder of International
Integration, Inc. (NASDAQ: ICUB), which merged with
Razorfish, Inc. (NASDAQ: RAZF) in November 1999. At
the time of the merger, I-Cube had $70 million in
revenues, with 600 consultants and 6 offices across
the United States and Europe. Mr. Anand holds a M.S.
in Computer Science from Northeastern University.
|
|
|
|
|
